Is there a role for cannabidiol in psychiatry?

Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors

(2016) A.G. Sartim et al.   BEHAVIOURAL BRAIN RESEARCH

Therapeutic Potential of Cannabinoids in Psychosis

(2016) F. Markus Leweke et al.   BIOLOGICAL PSYCHIATRY

An Introduction to the Endogenous Cannabinoid System

(2016) Hui-Chen Lu et al.   BIOLOGICAL PSYCHIATRY

Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings

(2016) Jose M. Trigo et al.   DRUG AND ALCOHOL DEPENDENCE

Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence

(2016) Jose M. Trigo et al.   Journal of Addiction Medicine

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

(2016) Orrin Devinsky et al.   LANCET NEUROLOGY

Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors

(2016) Raquel Linge et al.   NEUROPHARMACOLOGY

Cannabidiol, neuroprotection and neuropsychiatric disorders

(2016) Alline C. Campos et al.   PHARMACOLOGICAL RESEARCH

From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology

(2016) Alessia Ligresti et al.   PHYSIOLOGICAL REVIEWS

Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects

(2016) Aviva Breuer et al.   PLoS One

Does cannabidiol have a role in the treatment of schizophrenia?

(2016) Anand Gururajan et al.   SCHIZOPHRENIA RESEARCH

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

(2015) Brian Hutton et al.   ANNALS OF INTERNAL MEDICINE

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

(2015) R B Laprairie et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice

(2015) Felipe V. Gomes et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Cannabinoids for Medical Use

(2015) Penny F. Whiting et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Endocannabinoid System and its Modulation by Phytocannabinoids

(2015) Vincenzo Di Marzo et al.   Neurotherapeutics

Cannabidiol as a Potential Treatment for Anxiety Disorders

(2015) Esther M. Blessing et al.   Neurotherapeutics

Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine

(2015) J. F. C. Pedrazzi et al.   PSYCHOPHARMACOLOGY

Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal

(2014) David J. Allsop et al.   JAMA Psychiatry

Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings

(2013) Celia J.A. Morgan et al.   ADDICTIVE BEHAVIORS

Cannabidiol for the treatment ofcannabiswithdrawal syndrome: a case report

(2012) J. A. S. Crippa et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors

(2012) Alline Cristina Campos et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

(2012) Amir Englund et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Endocannabinoid system and mood disorders: Priming a target for new therapies

(2012) Vincenzo Micale et al.   PHARMACOLOGY & THERAPEUTICS

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

(2012) A. C. Campos et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

(2012) F M Leweke et al.   Translational Psychiatry

Endocannabinoid system dysfunction in mood and related disorders

(2011) C. H. Ashton et al.   ACTA PSYCHIATRICA SCANDINAVICA

Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study

(2011) Toby T Winton-Brown et al.   NEUROPSYCHOPHARMACOLOGY

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

(2011) Mateus M Bergamaschi et al.   NEUROPSYCHOPHARMACOLOGY

Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being

(2011) C. J. A. Morgan et al.   PSYCHOLOGICAL MEDICINE

Cannabis with high cannabidiol content is associated with fewer psychotic experiences

(2011) Christian D. Schubart et al.   SCHIZOPHRENIA RESEARCH

Updated Consolidated Standards of Reporting Trials (CONSORT): it just gets better

(2010) Maarten Boers   JOURNAL OF CLINICAL EPIDEMIOLOGY

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

(2010) José Alexandre S Crippa et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice

(2010) Felipe V. Gomes et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The interplay of cannabinoid and NMDA glutamate receptor systems in humans: Preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects

(2010) Jaime E.C. Hallak et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors

(2010) Felipe V. Gomes et al.   PSYCHOPHARMACOLOGY

Endocannabinoid Signaling and Long-Term Synaptic Plasticity

(2009) Boris D. Heifets et al.   Annual Review of Physiology

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

(2009) Paolo Fusar-Poli et al.   ARCHIVES OF GENERAL PSYCHIATRY

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors

(2009) TV Zanelati et al.   BRITISH JOURNAL OF PHARMACOLOGY

Imaging the Neural Effects of Cannabinoids: Current Status and Future Opportunities for Psychopharmacology

(2009) S. Bhattacharyya et al.   CURRENT PHARMACEUTICAL DESIGN

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

Cannabis and psychiatric disorders: it is not only addiction

(2008) F. Markus Leweke et al.   ADDICTION BIOLOGY

Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia

(2008) Stephen M. Eggan et al.   ARCHIVES OF GENERAL PSYCHIATRY

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

(2008) Celia J. A. Morgan et al.   BRITISH JOURNAL OF PSYCHIATRY

Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats

(2008) Rafael M. Bitencourt et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cannabidiol was ineffective for manic episode of bipolar affective disorder

(2008) AW Zuardi et al.   JOURNAL OF PSYCHOPHARMACOLOGY

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

(2008) Borwin Bandelow et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY